NHS Innovation and Technology Payment (ITP) & Innovation and Technology Tariff (ITT)
NHS Innovation and Technology Payment (ITP) programme
In some cases, proven innovations and technologies are being prevented from widespread adoption in the NHS due to financial or procurement barriers. In such cases, the NHS Innovation and Technology Payment (ITP) programme assists the NHS in adopting innovations and technologies with strong evidence that widespread adoption would improve the quality of healthcare and deliver efficiencies. Delivered in partnership with the Academic Health Science Networks, the programme helps to support the cultural change necessary for proven innovations to be adopted faster and more systematically through the NHS.
Successful innovations or technology have been identified through a competitive process led by NHS England. To ease adoption, NHS England reimburses individual NHS Trusts for the cost of using an innovation, or they have centrally procured innovations and technologies for use different geographical areas.
The 2018-19 ITP programme funds innovations including:
- Plus Sutures
- Endocuff Vision
- DrDoctor (in pilot areas)
HIN supports and encourages commissioners and providers to implement ITP innovations and technologies within south London Trusts. As such, the 18/19 ITP products have been trialled or adopted across six hospitals and NHS Trusts throughout south London. (Please note that south London providers are not eligible to use Plus Sutures as they do not meet the criteria for use).
NHS Innovation and Technology Tariff (ITT) programme: 2017 – 2019
Prior to the ITP The NHS Innovation and Technology Tariff (ITT) was established. In many cases an innovation may be funded under a simple zero cost model, where Trusts order an innovation directly from the supplier at no cost and NHS England then reimburses the supplier directly. These innovations and technologies must meet specific criteria.
The ITT programme offers funding for 24 months, after which funding may be renewed for some innovations and technologies. Products that were funded during the 2017/19 round included:
- Non-Injectable Arterial Connector Implementation.
HIN offers support to help commissioners and providers to implement the ITP innovations and technologies within south London. As such, ITT products have been trialled or adopted across seven hospitals and NHS Trusts.